Chenghai Liu

8PUBLICATIONS
66CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Predictive and prognostic markersChemotherapyHaematological tumoursTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 05, 2026
Chronic kidney disease in cirrhosis: a study of inpatients from a global perspective.

|Apr 27, 2026
Machine Learning Models Using Hospital Admission Characteristics Do Not Optimally Predict Nosocomial Infection Development in a Global Cirrhosis Cohort.

|May 23, 2024
Beneficial Effects of Traditional Chinese Medicine Fuzheng Huayu on the Occurrence of Hepatocellular Carcinoma in Patients with Compensated Chronic Hepatitis B Cirrhosis Receiving Entecavir: A Multicenter Retrospective Cohort Study.

Haina Fan, Shujuan Lei, Zhimin Zhao

|May 10, 2023
Cyp4a12-mediated retinol metabolism in stellate cells is the antihepatic fibrosis mechanism of the Chinese medicine Fuzheng Huayu recipe.

Da-Bing Ping, Xin Sun, Yuan Peng

|Nov 22, 2022
Antiliver Fibrosis Formula of Fuzheng Huayu Alleviates Inflammatory Response.

Qing-Qi Chang, Yi-Feng Pan, Jia-Yi Yang

|Jul 25, 2022
Efficacy and Safety of a Botanical Formula Fuzheng Huayu for Hepatic Fibrosis in Patients with CHC: Results of a Phase 2 Clinical Trial.

Tarek Hassanein, Dean Tai, Chenghai Liu

Pageof 2

Frequent Collaborators

2 joint publications

Hiang Keat Tan

2 joint publications

Zhujun Cao

2 joint publications

Anoop Saraya

2 joint publications

Jacob George